胆酸,它们的受体和MASH之间的多方面的相互作用:从分子机制到临床治疗方法
Xuan Tang1, Yuanjiao Zhou1, Li Xia1
1Key Laboratory for Quality Evaluation of Bulk Herbs of Hunan Province, School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China.
Molecules (Basel, Switzerland)
|August 14, 2025
概括
代谢功能障碍相关的脂肪肝炎 (MASH) 涉及脂质,炎症和纤维化乱. 胆酸及其受体是MASH疗法的关键点,提供了潜在的临床进展.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 代谢综合征研究 代谢综合征研究
- 胃肠病学 胃肠病学
背景情况:
- 代谢功能障碍相关的脂肪肝炎 (MASH) 是一种严重的肝脏疾病,与代谢综合征有关.
- 它的发展涉及脂质代谢,炎症和纤维化的复杂干扰.
- 肠肝轴,特别是胆酸及其受体,在MASH病变发生过程中起着至关重要的作用.
研究的目的:
- 系统地审查胆酸代谢和MASH中的信号传递的分子机制.
- 检查胆酸及其受体在肠肝轴中的作用,涉及MASH.
- 探索针对胆酸及其受体用于MASH治疗的治疗潜力.
主要方法:
- 关于分子机制的系统文献综述.
- 胆酸生物合成和代谢失调的分析.
- 在MASH中检查胆酸受体信号通路.
主要成果:
- 胆酸代谢和受体信号传递在MASH中显著改变.
- 这些变化会影响脂质代谢,炎症和纤维化进展.
- 胆酸及其受体代表了MASH的有希望的治疗点.
结论:
- 胆酸及其受体是MASH病原和进展的核心.
- 针对这些途径为新型MASH疗法提供了重要的翻译潜力.
- 对动态调节机制和组合疗法的进一步研究是有必要的.
相关概念视频
Hepatic Drug Excretion: Influencing Factors
218
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
218
Hepatic Drug Clearance: Role of Transporters
101
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
101
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
263
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
263
Bile
1.7K
Bile is a crucial bodily fluid, characterized by its yellow-green color and alkaline nature. Produced in the liver, it is transported through the common hepatic duct into either the cystic duct, leading to the gallbladder, or directly into the common bile duct. The flow of bile is regulated by the sphincter of Oddi located at the entrance of the duodenum. When this sphincter is closed, bile is redirected to the gallbladder for storage and concentration.
Bile is released when dietary fats enter...
Bile is released when dietary fats enter...
1.7K
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
80
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
80
Hepatic Drug Excretion: Enterohepatic Cycling
1.8K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.8K


